Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

New Qudexy XR Monotherapy Age Range

The FDA has approved a Supplemental New Drug Application (sNDA) for Qudexy XR (topiramate; Upsher-Smith) extended-release capsules for monotherapy in patients ages 2 to less than 10 years old with partial onset (POS) or primary generalized tonic-clonic (PGTC) seizures.

Physicians Not Disclosing Alzheimer's Diagnosis

In a new report from the Alzheimer's Association, only 45% of patients with Alzheimer's disease or their caregivers stated that they were told the diagnosis by their physician and were more likely to be told the diagnosis after the disease had become more advanced.

Methionine May Promote Memory Loss

A diet rich in methionine may promote memory loss through increased netrin methylation, scientists from University of Louisville reported.

Targeted Immunotherapy for Alzheimer's

Memory problems associated with Alzheimer's disease may one day be reversed with targeted immunotherapy, according to a new study

Coffee's Neuroprotective Effects Supported

People who drink several cups of coffee every day may have a decreased risk of developing multiple sclerosis (MS).

Cinnamon: A Future Treatment for MS?

Cinnamon has shown promise in helping diabetes patients with blood glucose control and in treatment of polycystic ovary syndrome (PCOS), and now the spice could one day benefit patients with multiple sclerosis (MS).

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

People with Dementia Often Not Screened

More than half of Americans with dementia have never undergone screening of their cognitive function.

News

Study Tests Extending Natalizumab Dosing Schedule in MS Patients

Research indicates that extending the dose of Tysabri (natalizumab; Biogen) from 4 weeks up to 8 weeks may be well tolerated and effective in patients with multiple sclerosis (MS).

FDA-Approved Antifungal, Corticosteroid Could Potentially Play a Role in Treating MS

An antifungal and a corticosteroid already approved by the Food and Drug Administration (FDA) have shown promise in activating oligodendrocyte progenitor cells (OPCs) to stimulate myelin-producing cells and repair white matter that is damaged in multiple sclerosis (MS).

New Data Released for Tecfidera in Multiple Sclerosis

Biogen announced that new data continues to support the use of Tecfidera (dimethyl fumarate) as an effective, long-term treatment for relapsing forms of multiple sclerosis.

FDA Addresses Investigational ALS Drug Concerns

The FDA issued a statement acknowledging the concerns about Genervon's investigational drug, GM604, for the treatment of amyotrophic lateral sclerosis (ALS).

FEATURES

Seizures Return After Initiating Vilazodone for MDD

Seizures Return After Initiating Vilazodone for MDD

Seizures induced by selective serotonin reuptake inhibitor (SSRI) use are rare and are more likely to be linked to larger doses and severe symptoms (such as those present in serotonin syndrome), but a new case study in the journal Pharmacotherapy described a patient that developed seizures after vilazodone treatment was initiated.

Is Roseroot a Reliable Alternative for Nervous System Ailments?

Is Roseroot a Reliable Alternative for Nervous System Ailments?

The perennial plant has been used to treat depression, muscle weakness and muscle fatigue.

Treating Traumatic Brain Injury in Young Athletes

Treating Traumatic Brain Injury in Young Athletes

Accurate identification, assessment and evaluation of concussions will enable clinicians to determine when it is safe for young athletes to return to competition.

Featured courses from mycme

Delayed Autism Diagnosis Common in Primary CareExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Headaches: Assessing and ManagementExternal web site

This session will provide the nurse practitioner with information about how to differentiate various types ...

CE 1.00 Credits

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular DisordersExternal web site

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...

CME 31.50 Credits

Sign Up for Free e-newsletters